scholarly journals Cyclosporine as a novel treatment for amatoxin-containing mushroom poisoning: a case series

2022 ◽  
Vol 6 (1) ◽  
pp. 23-27
Author(s):  
Constance A. Mackenzie ◽  
Emily Austin ◽  
Margaret Thompson ◽  
Rommel G. Tirona
2020 ◽  
Vol 8 ◽  
pp. 2050313X1990107 ◽  
Author(s):  
Erin Streu ◽  
Marni C Wiseman ◽  
James B Johnston

Intravenous immunoglobulin is a recognized treatment in recalcitrant autoimmune bullous diseases. Infusions are administered monthly over 1–5 days in the hospital setting and associated with mild to severe infusion-related systemic effects, in part due to the high doses necessary to induce and achieve remission. We present a case series of four patients with bullous diseases treated successfully with low-dose subcutaneous IgG who achieved remission with maintenance therapy. Patient-administered smaller, more frequent doses of IgG into subcutaneous tissue more closely mimics the body’s own antibody production and produces a more stable serum trough level. Subcutaneous IgG is a novel treatment approach in bullous diseases which can induce a state remission.


2009 ◽  
Vol 47 (6) ◽  
pp. 562-565 ◽  
Author(s):  
Yael Lurie ◽  
Solomon P Wasser ◽  
Muhammad Taha ◽  
Haj Shehade ◽  
Josef Nijim ◽  
...  

2018 ◽  
Vol 78 (1) ◽  
pp. 190-192 ◽  
Author(s):  
Kara Hoverson ◽  
Tracy Love ◽  
Thomas K. Lam ◽  
Jason D. Marquart

2018 ◽  
Vol 33 (6) ◽  
pp. 638-644 ◽  
Author(s):  
Caroline Ovadia ◽  
Anita Lövgren-Sandblom ◽  
Lindsey A. Edwards ◽  
Jacqueline Langedijk ◽  
Victoria Geenes ◽  
...  

2017 ◽  
Vol 25 (5) ◽  
pp. 251-259 ◽  
Author(s):  
Robinetta Hudson ◽  
Russell T. Baker ◽  
James May ◽  
Don Reordan ◽  
Alan Nasypany

Sign in / Sign up

Export Citation Format

Share Document